Specialty Oncology
-
Featured
Biomarkers of T Cell Exhaustion in Checkpoint Inhibitor Therapy
Could altering the balance between two CD8+ T cell states enhance immunotherapies? Research from the Massachusetts General Hospital Cancer Center seeks to find the answer.
-
Long-term Safety Profile of Salvage Cystectomy After Trimodality Therapy Seems Acceptable
Salvage cystectomy after trimodality therapy is associated with a higher rate of late complications than primary cystectomy, according to Matthew F. Wszolek, MD, and colleagues. However, the increased risk of late complications does not influence overall survival.
-
Nutritional, Physiological Factors Affect Wound Infection After Surgery for Lower-Extremity Soft Tissue Sarcoma
Researchers from the Orthopaedic Oncology Service found that low albumin, poor nutrition, elevated postoperative glucose and tobacco use are risk factors for wound infection and the need for additional surgery after resection of lower-extremity soft tissue sarcoma.
-
Advances in Prehabilitation
Motaz Qadan, MD, PhD, is a hepatobiliary and pancreatic surgical oncologist in the Mass General Cancer Center and a surgeon in the Division of Gastrointestinal and Oncologic Surgery. In this video, he discusses his research on prehabilitation and its promising potential for patients with pancreatic cancer.
-
Ortho-Oncology at Mass General: Spirit of Collaboration
In this video, ortho-oncology surgeon Santiago Lozano-Calderon, MD, PhD, discusses the research environment at Massachusetts General Hospital.
-
Review: Challenges in Discovering Extracellular Vesicle–based Cancer Biomarkers
Anudeep Yekula, MD, Leonora Balaj, PhD, and Bob S. Carter, MD, PhD, of the Department of Neurosurgery, highlight hurdles in the process of developing extracellular vesicle–based cancer biomarkers, from discovery to clinical application.
Mass General Cancer Center Contributors
-
Andrew T. Chan, MD, MPH
Professor of Medicine, Harvard Medical School, Director for Cancer Epidemiology, Mass General Cancer Center, Chief, Clinical and Translational Epidemiology Unit, Department of Medicine
Recent Article
Advances in Diverticulitis Treatment and Prevention
-
David M. Langenau, PhD
Associate Professor of Pathology, Harvard Medical School, Associate Chair for Research, Department of Pathology, Massachusetts General Hospital
-
J. Keith Joung, MD, PhD
Professor of Pathology, Harvard Medical School, Center for Cancer Research, Desmond and Ann Heathwood MGH Research Scholar
Recent Article
CRISPR Base Editors Can Induce Wide-Ranging Off-Target Edits in RNA
-
Joseph H. Schwab, MD
Chief, Orthopaedic Spine Surgery, Director, Spine Oncology & Co-Director, Stephen L. Harris Chordoma Center, Associate Professor of Orthopaedic Surgery, Harvard Medical School
Recent Article
Nutritional, Physiological Factors Affect Wound Infection After Surgery for Lower-Extremity Soft Tissue Sarcoma
-
Keith T. Flaherty, MD
Director of Clinical Research, Mass General Cancer Center, Professor of Medicine, Harvard Medical School
Recent Article
Medical Grand Rounds: Advancing New Therapies for COVID-19: Antiviral, Immunomodulation and Beyond
-
Marcela G. del Carmen, MD
Chief Medical Officer, Massachusetts General Physicians Organization and Massachusetts General Hospital, Gynecologic Oncologist, Department of Obstetrics and Gynecology, Clinician, Center for Gynecologic Oncology, Mass General Cancer Center
Recent Article
U.S. COVID-19 Test Results Strongly Correlate with Race/Ethnicity, Income
-
Marcela V. Maus, MD, PhD
Director, Cellular Immunotherapy Program, Mass General Cancer Center, Assistant Professor of Medicine, Harvard Medical School
Recent Article
CAR T-cell Therapy Feasible for Active Secondary CNS Lymphoma -
Nir Hacohen, PhD
Director, MGH Center for Cancer Immunology
Center for Cancer Research , Professor of Medicine, Harvard Medical School, Senior Member, Broad InstituteRecent Article
Mass General Researchers Find Link Between Protein Signature and Severe Health Decline in COVID-19 Patients
-
Raul Mostoslavsky, MD, PhD
Laurel Schwartz Professor of Medicine in the Field of Oncology, Mass General Cancer Center, Center for Cancer Research
Recent Article
Inactivating Mutation in the Histone Deacetylase SIRT6 Discovered to Be a Cause of Fetal Demise
-
Whitfield B. Growdon, MD
Center for Gynecologic Oncology
Recent Article
Understanding the Molecular Underpinnings of Gynecologic Cancers
-
William T. Curry, MD
Co-Director, Mass General Neuroscience , Director of Neurosurgical Oncology
Recent Article
Immunotherapies to Treat Glioblastoma
Mass General Cancer Center
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.
